Senior Director, Portfolio Integration Lead - Hematology

About the role

The Portfolio Integration Lead (PIL) is a senior role in Oncology Clinical Development, responsible for shaping the advancement of multiple oncology programs from our portfolio with a focus on particular cancers. Working closely with both the VP and Clinical Development Leads (CDLs) and cross-functional teams across GSK, this role ensures scientific alignment, portfolio coherence, and development excellence across assets.

Responsibilities

• Provide senior scientific partnership to CDLs, particularly in areas such as disease biology, biomarker strategy, and novel treatment combinations development.
• Ensure consistent cross-programme ways of working to improve development efficiency and execution.
• Drive cross-programme portfolio working groups and ensure business level alignment.
• Drive and support clinical trial innovation based on evolving oncology treatment landscape, government regulations, basic/translational science, and emerging technologies (such as AI-enabled tools).
• Strengthen the scientific and strategic positioning of a pan-asset portfolio across multiple clinical and pre-clinical assets.
• Drive initiatives that advance data and technology strategies supporting development decision-making.
• Shape engagement with external experts and governance bodies including advisory boards where relevant.

Requirements

In this role, you will:

• Provide senior scientific partnership to CDLs, particularly in areas such as disease biology, biomarker strategy, and novel treatment combinations development.
• Ensure consistent cross-programme ways of working to improve development efficiency and execution.
• Drive cross-programme portfolio working groups and ensure business level alignment.
• Drive and support clinical trial innovation based on evolving oncology treatment landscape, government regulations, basic/translational science, and emerging technologies (such as AI-enabled tools).
• Strengthen the scientific and strategic positioning of a pan-asset portfolio across multiple clinical and pre-clinical assets.
• Drive initiatives that advance data and technology strategies supporting development decision-making.
• Shape engagement with external experts and governance bodies including advisory boards where relevant.

Qualifications

• Bachelor’s / Master’s / Advanced degree in a scientific or medical discipline.
• Candidates may come from a medical or scientific background; oncology drug development expertise with defined experience is expected.
• 10+ years of experience in oncology drug development within pharmaceutical or biotechnology environments, including involvement across multiple programs or assets.
• Experience of clinical development processes, regulatory pathways, and oncology therapeutic landscapes.
• Experience in operating structured matrix organizations and demonstrate decision-making and stakeholder engagement at senior organizational levels.

Skills

• Clinical Data Interpretation
• Clinical Trial Designs
• Clinical Trials Monitoring
• Digital Fluency
• Drug Development
• Drug Regulatory Affairs
• Evidence Based Decision Making
• Executive Presence
• Hematology and Oncology
• Learning Agility
• Matrix Leadership
• Real World Evidence (RWE)
• Scientific Presentations
• Strategic Direction

Pay

The annual base salary for new hires in this position ranges $242,250 to $403,750.

Schedule

This role offers a hybrid working model, with a mix of on-site and remote work.